Safety & Efficacy of Oral LPCN 1021 in Men With Low Testosterone or

Updated 04/30/2024

Status Completed

Clinical Trial Summary

The purpose of this study is to determine the safety and efficacy of an oral testosterone undecanoate formulation for use as testosterone-replacement therapy in men with low testosterone.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02081300
Study type	Interventional
Source	Lipocine Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	February 2014
Completion date	May 2015

See also
	Status	Clinical Trial	Phase
	Completed	`NCT01446042` - Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism	Phase 3
	Completed	`NCT02966652` - Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism	Phase 1
	Completed	`NCT01228071` - Time to Eugonadal Range, Time to Steady State and Drying Time	Phase 3
	Withdrawn	`NCT02715713` - Autonomic Manifestations of Testosterone Deficiency in Men	N/A
	Completed	`NCT00858650` - Registry of Hypogonadism in Men	N/A
	Recruiting	`NCT05541172` - Testosterone Undecanoate Replacement Therapy in Boys With Pubertal Delay or Confirmed Hypogonadism
	Not yet recruiting	`NCT04704141` - Relationship of the Microenvironment and Male Fertility
	Completed	`NCT01403116` - Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men	Phase 3
	Completed	`NCT00911586` - Pharmacokinetic Study to Determine Time to Steady-state	Phase 2
	Completed	`NCT00924612` - Study to Determine the Effect of Food on the Absorption of an Oral Testosterone Undecanoate Formulation	Phase 2
	Completed	`NCT01765179` - Safety and Efficacy Trial of Testosterone Undecanoate	Phase 3
	Completed	`NCT00475501` - 5-Alpha Reductase and Anabolic Effects of Testosterone	Phase 2
	Completed	`NCT04708249` - D-chiroinositol Administration in Hypogonadal Males	N/A
	Active, not recruiting	`NCT03721497` - Testosterone in Bariatric Patients	Phase 4
	Completed	`NCT01699178` - Open-label, Follow-up Study of Oral Testosterone Undecanoate in Hypogonadal Men	Phase 3